MMSI Merit Medical Systems Inc.

Merit Medical Announces Resignation of President, Joseph Wright

Merit Medical Announces Resignation of President, Joseph Wright

SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or the “Company”), a global leader of healthcare technology, today announced the resignation of its President, Joseph C. Wright, effective January 3, 2025.

The Company noted that prior to Mr. Wright’s resignation, Merit had received notice of allegations regarding his conduct, which Merit’s independent directors investigated with the assistance of independent counsel. The allegations were unrelated to Merit’s operations or financial performance.

Based upon Mr. Wright’s resignation, Merit’s Board of Directors has re-appointed Fred P. Lampropoulos as Merit’s President.

ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 700 individuals. Merit employs approximately 7,200 people worldwide. 

CONTACTS 

PR/Media Inquiries 

Sarah Comstock 

Merit Medical 

|   



EN
16/12/2024

Underlying

MMSIMerit Medical Systems Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE
Free
MMSI Merit Medical S...

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable ...

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY informational call on January 28, 2025 SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that the WRAPSODY® Cell-Impermeable Endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this approval, Merit can begin commer...

December 20, 2024 1 EN
 PRESS RELEASE
Free
MMSI Merit Medical S...

Merit Medical Announces Resignation of President, Joseph Wright

Merit Medical Announces Resignation of President, Joseph Wright SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or the “Company”), a global leader of healthcare technology, today announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. The Company noted that prior to Mr. Wright’s resignation, Merit had received notice of allegations regarding his conduct, which Merit’s independent directors investigated with the assistance of independent counsel. The allegations were unrelated to Merit’s operation...

December 16, 2024 1 EN
 PRESS RELEASE
Free
MMSI Merit Medical S...

Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arte...

Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial SOUTH JORDAN, Utah, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive six-month findings from the single-arm AVG cohort of its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial. The data were presented at the 51st annual VEITHsymposium during the Novel Technologies in Hem...

November 25, 2024 1 EN
 PRESS RELEASE
Free
MMSI Merit Medical S...

Merit Medical Completes Acquisition of Lead Management Portfolio from ...

Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of certain liabilities. Merit funded the acquisition payment through a combination of cash on hand and borrowings under its long-term credit facility. “We are pleased to...

November 1, 2024 1 EN
 PRESS RELEASE
Free
MMSI Merit Medical S...

Merit Medical Reports Third Quarter 2024 Results and Raises Full-Year ...

Merit Medical Reports Third Quarter 2024 Results and Raises Full-Year Guidance Third Quarter 2024 Highlights† Reported revenue of $339.8 million, up 7.8%Constant currency revenue* and constant currency revenue, organic* up 7.9% and up 5.7%, respectivelyGAAP operating margin of 11.0%, compared to 11.1% in prior year periodNon-GAAP operating margin* of 19.2%, compared to 17.4% in prior year periodGAAP EPS $0.48, up 8.0%, and non-GAAP EPS* $0.86, up 21.1%Generated free cash flow* $120 million over the first nine months of 2024, up 116% year-over-yearCompleted the acquisition of certain asse...

October 30, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch